The Technical Analyst
Select Language :
Merus NV [MRUS]

Exchange: NASDAQ Global Market Sector: Healthcare Industry: Biotechnology

Merus NV Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Merus NV is listed at the NASDAQ Exchange

-1.37% $22.33

Last updated: 3 jul 2022 - 19:57

TimeZone: America/New_York


FUNDAMENTALS
MarketCap: 972.47 mill
EPS: -1.867
P/E: 0.000
Earnings Date: Aug 03, 2022
SharesOutstanding: 43.55 mill
Avg Daily Volume: 0.367 mill
RATING 2022-07-01
B+
Buy
RATINGDETAILS
Rating CashFlow: Strong Buy
Return On Equity: Neutral
Return On Asset: Neutral
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
4/201/212/213/214/211/22
Revenue
Gr.Profitn/an/an/an/an/an/a
Ebit
Asset
Debt
DISCOUNTED CASH FLOW VALUE
$28.58
(27.98%) $6.25
Date: 2022-07-03
True Range Average
+/- $1.487
( +/- 6.66%)
Range: 20.84 - 23.82
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2022-06-01 Shuman Harry Sell 2 500 Restricted Share Unit
2022-06-01 Shuman Harry Sell 575 Common Shares
2022-06-01 Shuman Harry Buy 2 500 Common Shares
2022-05-31 Iwicki Mark T Buy 16 604 Share option (right to buy)
2022-05-31 Perry Gregory D Buy 16 604 Share option (right to buy)
INSIDER POWER
-8.16
Last 100 transactions
Buy: 3 806 205 | Sell: 3 624 056

Forecast: 16:00 - $22.33

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $22.33
Forecast 2: 16:00 - $22.33
Forecast 3: 16:00 - $22.33
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $22.33 (-1.37% )
Volume 0.166 mill
Avg. Vol. 0.367 mill
% of Avg. Vol 45.29 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Merus NV

Last 12 Months

Last 12 months chart data with high, low, open and close for Merus NV

RSI

Intraday RSI14 chart for Merus NV

Last 10 Buy & Sell Signals For MRUS

22 Signals | Accuracy: 31.82% | Accuracy Buy: 36.36% | Accuracy Sell: 27.27%

Avg return buy: -0.11 % | Avg return sell: 0.25 %

$1 invested is now $0.99 or -1.26% since 30-06-22

Date Signal @ Closed %
Jun 30 - 09:50sell$22.05$22.17 @ Jun 30 - 12:340.54%
Jun 30 - 09:45buy$22.10$22.05 @ Jun 30 - 09:50-0.23%
Jun 30 - 09:30sell$22.10$22.10 @ Jun 30 - 09:450.00%
Jun 30 - 09:29buy$22.11$22.10 @ Jun 30 - 09:30-0.05%
The Live Chart for Merus NV
Profile picture for
            Merus NV

MRUS

Merus NV is a clinical-stage immune-oncology company, which engages in the discovery and development of bi-specific antibody therapeutics. The company is headquartered in Utrecht, Utrecht and currently employs 98 full-time employees. The firm develops differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Biclonics format. Its products include, among others, MCLA-134 that is designed to bind to a combination of two immunomodulatory targets expressed by T cells, as well as MCLA-145 that is designed to bind to a tumor-associated target with an immunomodulatory target involved in checkpoint inhibition.

Last 10 Buy Signals
Date Signal @
PPTUSDJul 3 - 19:550.115
NXSUSDJul 3 - 19:550.136
UBQUSDJul 3 - 19:550.0337
BNTUSDJul 3 - 19:540.488
DCRUSDJul 3 - 19:5422.62
LINKUSDJul 3 - 19:546.20
BLOCKUSDJul 3 - 19:510.183
ARKUSDJul 3 - 19:490.423
MAIDUSDJul 3 - 19:480.184
GAMEUSDJul 3 - 19:480.0152

Stock Peers

Company Price Change
MRUS22.33-1.37%
CDXS10.884.02%
EOLS11.690.78%
HSTM21.900.88%
NKTR3.75-1.32%
OTRKP3.001.69%
RCKT14.455.01%
RNA15.466.40%
SVA6.470.00%
TOI5.274.15%
VERV15.632.29%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.